Thursday, October 30, 2014

18:00-19:15 Opening Session 

Keynote speaker and prize ceremony

19:15-20:30 Networking reception


Friday , October 31, 2014

  Hall A Hall B

Plenary Session I:

Screening for thrombophilia and pregnancy complications

10:30-11:00 Coffee break and poster viewing

Parallel Session II:

Heparin, Warfarin and novel anticoagulants

Parallel Session III:

Epidemiology and risk factors of venous thrombosis in children

13:00-14:00 Lunch break and poster viewing

Plenary Session IV:

Hemophilia care: Current guidelines and applications of new factor concentrates 
16:00-16:30 Coffee break and poster viewing 

Parallel Session V:

Antiplatelet therapy and monitoring

Parallel Session VI:

Replacement therapy before surgery of FVII & FXI deficient patients


Saturday, November 1, 2014

  Hall A Hall B


Industry Symposium
Session not included in main CME/CPD credit program
For more information, click here

10:00-10:30 Coffee break and poster viewing

Parallel Session VII:

Pharmacogenomics; Thrombolytic therapy

Parallel Session VIII:

Heparins, warfarin and new anticoagulants for  pediatric venous thrombosis 

12:30-13:30 Lunch break and poster viewing

Plenary Session IX:

Immune thrombocytopenia; Bleeding complications of new oral anticoagulants

15:30-16:00 Coffee break and poster viewing 

Parallel Session X:

Primary prevention of venous thrombosis and coronary artery disease

Parallel Session XI:

Plasma derived versus recombinant factor VIII concentrates 


Thrombotic disorders and anti-thrombotics

Bleeding disorders


Industry session